橘红胶囊联合阿斯美治疗老年慢性支气管炎急性发作临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R562.2+1

基金项目:


Clinical Study on Juhong Capsules Combined with Asmeton for Acute Attack of Chronic Bronchitis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察橘红胶囊联合阿斯美治疗老年慢性支气管炎(简称老慢支) 急性发作的临床疗效及其对血清前白蛋白(PA)、C-反应蛋白(CRP) 影响。方法:选取67 例老慢支急性发作患者为研究对象,根据不同治疗方法分为试验组37 例和对照组30 例。2 组均给予基础治疗,对照组加用复方甲氧那明胶囊(阿斯美) 治疗,试验组在对照组的基础上加用橘红胶囊治疗。观察2 组临床疗效及不良反应发生率,比较治疗前后2 组主要症状及体征评分、血清PA 及CRP 水平。结果:试验组总有效率为97.30%,对照组为76.67%,2 组比较,差异有统计学意义(P<0.05)。治疗前,2 组主要症状咳嗽、咳痰、喘息、痰色质评分比较,差异无统计学意义(P>0.05);治疗后,2 组上述各项评分均较治疗前降低(P<0.05),且试验组各项评分均低于对照组(P<0.05)。治疗前,2 组次要症状胸胁胀满、发热、胸部X 线评分比较,差异无统计学意义(P>0.05);治疗后,2 组上述各项评分均较治疗前降低(P<0.05),且试验组各项评分均低于对照组(P<0.05)。治疗前,2 组血清PA、CRP 水平比较,差异无统计学意义(P>0.05);治疗后,2 组PA 水平较治疗前升高(P<0.05),CRP 水平较治疗前降低(P<0.05),且试验组PA、CRP 水平改善较对照组更显著(P<0.05)。试验组不良反应发生率为2.70%,对照组为20.00%,2 组比较,差异有统计学意义(P<0.05)。结论:橘红胶囊联合阿斯美治疗老慢支急性发作期患者疗效显著,能有效升高血清PA 水平,降低CRP 水平,改善患者临床症状,且不良反应较少。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Juhong capsules combined with Asmeton for acute attack of chronic bronchitis and its effect on prealbumin(PA) and C- reactive protein(CRP) in serum. Methods:A total of 67 cases of patients with acute attack of chronic bronchitis were selected as the study objects and divided into the experiment group and the control group according to different treatment methods,with 37 and 30 cases in each group respectively. Both groups were given basic treatment;the control group was additionally treated with compound methoxyphenamine capsules(Asmeton), and the experiment group was additionally treated with Juhong capsules based on the treatment of the control group. Clinical effects and the incidence of adverse reactions in the two groups were observed. Scores of main symptoms and signs and levels of PA and CRP in serum in the two groups before and after treatment were compared. Results:The total effective rate was 97.30% in the experiment group,and 76.67% in the control group, the difference being significant(P<0.05). Before treatment, there was no significant difference being found in the comparison of scores of main symptoms including cough, expectoration, panting, and the color and feature of phlegm between the two groups(P>0.05); after treatment, the above scores in the two groups were decreased when compared with those before treatment(P<0.05), and each score in the experiment group was lower than that in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of scores of minor symptoms including distention and fullness in the chest and hypochondrium,fever,and chest X-ray between the two groups(P>0.05); after treatment, the above three scores in the two groups were decreased when compared with those before treatment(P<0.05),and each score in the experiment group was lower than that in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of levels of PA and CRP in serum between the two groups(P>0.05);after treatment,the PA levels in the two groups were increased when compared with those before treatment(P<0.05),CRP levels were decreased(P<0.05), and the improvement of the two levels in the experiment group was more significant than that in the control group(P<0.05). The incidence of adverse reactions was 2.70% in the experiment group, and 20.00% in the control group, there being significance in the difference(P<0.05). Conclusion: Juhong capsules combined with Asmeton has a significant difference in the treatment of patients with acute attack of chronic bronchitis. It can effectively improve PA level in serum,reduce CRP level,and improve clinical symptoms with few adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

谢丽君,缪克己.橘红胶囊联合阿斯美治疗老年慢性支气管炎急性发作临床研究[J].新中医,2022,54(16):73-77

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-08-28
  • 出版日期:
文章二维码